Trials / Unknown
UnknownNCT06113094
Cryoablation for Advanced and Refractory Desmoid Tumors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Desmoid tumors, also called aggressive fibromatosis, are rare, locally invasive tumors with no potential for metastasis. The incidence is approximately 2 to 4 per million per year in the general population. The "watch and wait" policy is the standard of care for newly diagnosed patients in Europe. Patients who progress have first-line medical treatment, surgery is no longer the treatment because there is a high rate of recurrence (\> 60%) and radiotherapy is not very suitable because the patients are often young and the tumors are large. Cryoablation seems to be an effective therapeutic option that should be evaluated.
Conditions
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2023-12-01
- Completion
- 2023-12-31
- First posted
- 2023-11-02
- Last updated
- 2023-11-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06113094. Inclusion in this directory is not an endorsement.